Bb Biotech as of Sept. 30, 2015
Portfolio Holdings for Bb Biotech
Bb Biotech holds 28 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 13.1 | $414M | 3.8M | 110.33 | |
| Celgene Corporation | 12.3 | $388M | 3.6M | 108.17 | |
| Radius Health | 9.4 | $296M | 4.3M | 69.31 | |
| Gilead Sciences (GILD) | 8.6 | $272M | 2.8M | 98.19 | |
| ISIS Pharmaceuticals | 8.5 | $268M | 6.6M | 40.42 | |
| Alexion Pharmaceuticals | 5.1 | $162M | 1.0M | 156.39 | |
| Agios Pharmaceuticals (AGIO) | 4.7 | $149M | 2.1M | 70.59 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.5 | $142M | 1.4M | 104.14 | |
| Neurocrine Biosciences (NBIX) | 4.0 | $126M | 3.2M | 39.79 | |
| Medivation | 3.5 | $110M | 2.6M | 42.50 | |
| Regeneron Pharmaceuticals (REGN) | 3.0 | $95M | 205k | 465.14 | |
| Halozyme Therapeutics (HALO) | 3.0 | $93M | 6.9M | 13.43 | |
| Alnylam Pharmaceuticals (ALNY) | 2.9 | $91M | 1.1M | 80.36 | |
| Novavax | 1.9 | $59M | 8.3M | 7.07 | |
| Clovis Oncology | 1.8 | $57M | 618k | 91.96 | |
| Juno Therapeutics | 1.7 | $53M | 1.3M | 40.69 | |
| Cempra | 1.7 | $53M | 1.9M | 27.84 | |
| Alder Biopharmaceuticals | 1.6 | $50M | 1.5M | 32.76 | |
| Tesaro | 1.5 | $46M | 1.2M | 40.10 | |
| Kite Pharma | 1.3 | $42M | 750k | 55.68 | |
| Puma Biotechnology (PBYI) | 1.2 | $39M | 522k | 75.36 | |
| Intercept Pharmaceuticals In | 1.1 | $35M | 211k | 165.86 | |
| Ptc Therapeutics I (PTCT) | 1.1 | $35M | 1.3M | 26.70 | |
| Infinity Pharmaceuticals (INFIQ) | 0.7 | $23M | 2.7M | 8.45 | |
| Esperion Therapeutics (ESPR) | 0.7 | $21M | 909k | 23.59 | |
| Prothena (PRTA) | 0.5 | $15M | 320k | 45.34 | |
| Tetraphase Pharmaceuticals | 0.3 | $11M | 1.5M | 7.46 | |
| Achillion Pharmaceuticals | 0.3 | $8.8M | 1.3M | 6.91 |
